Month: May 2020

Performance solide au premier trimestre permettant à Bekaert de bien se positionner face à la criseConditions de travail saines – orientation client – position solide de liquidité Faits marqantsMesures exhaustives pour protéger les employés, avec un nombre limité d’infections Covid-19Chiffre d’affaires en baisse de -11% en raison des confinements imposés par les gouvernements et de la baisse de la demande mondiale sur les marchés des pneumatiques et de l’automobileMesures efficaces de réduction des coûts en placeLiquidités en hausse de plus de € 190 millions par rapport à fin 2019 et fonds en caisse de plus de € 750 millionsLevier d’endettement stable depuis fin 2019 à 2,1x l’EBITDA sous-jacentProposition de dividende brut de € 0,35 avec versement différé au 20 novembre 2020PerspectivesNous prévoyons une baisse sensible du...

ASKER, NORWAY (13 May 2020) – Following the authorization from the Annual General Meeting on 8 May 2019, the Board of TGS NOPEC Geophysical Company ASA has resolved to distribute a quarterly dividend of the NOK equivalent of USD 0.125 per share (NOK 1.27 per share) in Q2 2020.Key information relating to the cash dividend:Dividend amount and declared currency: USD 0.125 per share (equivalent to NOK 1.27 per share)Last trading day including right: 19 May 2020Ex-date: 20 May 2020Record date: 22 May 2020Payment date: 3 June 2020Date of approval: 12 May 2020Company summary     TGS-NOPEC Geophysical Company (TGS) provides multi-client geoscience data to oil and gas Exploration and Production companies worldwide.  In addition to extensive global geophysical and geological data libraries that include multi-client seismic data, magnetic and gravity...

The organisation of public or private events has been banned by European states until different dates. As a precautionary measure to reduce any risk of a new coronavirus, the Board of Directors of Eastern Property Holdings Ltd. (hereinafter the “Company”) decided to only invite its two major shareholders to the physical meeting and ask all other shareholders to exercise their rights exclusively through the independent proxy. Please refer to the invitation under item 7 for information on how to authorize and instruct the independent proxy.NOTICE is hereby given that the Annual General Meeting of the Company will be held on 16 June 2020 at 11:00 AM at Sele Frommelt & Partner Rechtsanwälte, Meierhofstrasse 5, 9490 Vaduz, Liechtenstein with only the chairman representative, auditor, independent proxy and the two main shareholders...

Regulatory release13 May 2020, 7 a.m.Business update Q1 2020 attached.AttachmentEN Business Update Q1 2020_FINAL

Information réglementéeLe 13 mai 2020, 07h00Business update T1 2020 en annexe.Pièce jointeFR Business Update Q1 2020_FINAL

Gereglementeerd bericht13 mei 2020, 07u00Business update Q1 2020 in bijlage.BijlageNL Business Update Q1 2020_FINAL

Louvain-La-Neuve, Belgium, 13 May 2020 – IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces its business update for the first quarter ending 31 March 2020.Business operations in the first quarter remained solid with some inevitable delays in the installation of projects starting to emerge as a result of the COVID-19 pandemic. In spite of the ongoing crisis, all of IBA’s operating proton therapy centers continue to treat patients with the Services business remaining at normal levels. Other Accelerators also had a solid start to the year with three new sales to date. Dosimetry continued to perform strongly in the first quarter, although some disruption from COVID-19 is expected to impact the business going forward, mirroring the impact seen...

Louvain-la-Neuve, Belgique, le 13 mai 2019 – IBA (Ion Beam Applications S.A.), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, publie aujourd’hui une revue de ses activités au 31 mars 2019.La conduite des activités lors de ce premier trimestre reste solide avec néanmoins l’émergence de quelques retards inévitables dans les projets d’installation en raison de la pandémie du COVID-19. Malgré la crise en cours, tous les centres de protonthérapie IBA en opérations continuent de traiter des patients avec une activité de Services qui reste à un niveau habituel. La division Autres Accélérateurs a vu également un début d’année solide avec trois nouvelles ventes à ce jour. La Dosimétrie a continué de réaliser de fortes performances au cours de ce premier trimestre. Néanmoins, quelques perturbations...

ASKER, NORWAY (13 May 2020) – TGS today reported net segment revenues of USD 152 million for Q1 2020, a 3% decline compared to Q1 2019. The quarter saw solid pre-funding revenues driven by Latin America and North America onshore, while late sales were hurt by the COVID-19 crisis and the large oil price drop towards the end of the quarter.At USD 125 million, EBITDA* in Q1 2020 came in 1% above Q1 2019 as a result of favorable development in operating costs.TGS continues to deliver industry-leading Return on Average Capital Employed (ROACE) with 17% annual return as per the end of Q1 2020.TGS’ balance sheet remains strong, with a cash holding of USD 248 million at 31 March 2020, allowing the Company to pay a dividend of USD 0.125 per share in Q2 2020, despite the challenging market conditions.On 8 April 2020 TGS announced several measures...

ABN AMRO rapporteert nettoverlies van EUR 395 miljoen over Q1 2020Nettoverlies vanwege hoge kredietvoorzieningen door corona, olieprijzen en marktontwikkelingenOndersteunen van onze klanten tijdens corona crisis; diverse maatregelen geïmplementeerdContinue dienstverlening dankzij digitale propositie en beeldbankieren, werkend vanaf huisSterke operationele resultaten; netto rentebaten op peil en provisiebaten hogerKosten lager dankzij verdere kostenbeheersingSterke kapitaalpositie; Basel III CET1 ratio van 17,3% en onder Basel IV circa 14%Review van strategie gestart om zeker te stellen dat we leveren op de strategische pijlers; update na de zomerPrioriteiten: impact corona crisis , CIB-review en AML-activiteitenRobert Swaak, CEO:“De corona pandemie is bovenal een persoonlijke gezondheidscrisis, maar het heeft ook een significante impact...